✦ LIBER ✦

Hypertrophy due to chronic volume overloading in the dog heart. A morphometric study

✍ Scribed by B. Winkler; J. Schaper; K. -U. Thiedemann

Publisher: Springer
Year: 1977
Tongue: English
Weight: 532 KB
Volume: 72
Category: Article
ISSN: 0300-8428
DOI: 10.1007/bf01906365

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Myocardial Morphological Characteristics

Myocardial Morphological Characteristics and Proarrhythmic Substrate in the Rat Model of Heart Failure Due to Chronic Volume Overload

✍ Jiri Benes JR.; Vojtech Melenovsky; Petra Skaroupkova; Jana Pospisilova; Jiri Pe 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 839 KB

## Abstract Chronic volume overload leads to cardiac hypertrophy and later to heart failure (HF), which are both associated with increased risk of cardiac arrhythmias. The goal of this study was to describe changes in myocardial morphology and to characterize arrhythmogenic substrate in rat model o

Adaptations of the left ventricle to chr

Adaptations of the left ventricle to chronic volume overload induced by mitral regurgitation in conscious dogs

✍ Jong Dae Lee; Shigetake Sasayama; Yasuki Kihara; Akira Ohyagi; Akiko Fujisawa; Y 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 948 KB

A preliminary study of the dopamine DA1a

A preliminary study of the dopamine DA1agonist fenoldopam in the treatment of chronic left ventricular failure due to ischaemic heart disease

✍ T. M. MacDonald; R. F. Jeffrey; A. L. Muir; M. R. Lee 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 219 KB

The effects of chronic oral fenoldopam in the treatment of NYHA grade II-III heart failure secondary to ischaemic heart disease, were studied in a placebo controlled, double blind, randomised, parallel group fashion in 20 patients. Nine patients taking placebo and six taking fenoldopam completed the

Cenderitide (CD-NP), a novel peptide des

Cenderitide (CD-NP), a novel peptide designed to activate both guanylyl cyclase B and A, activates the second messenger cGMP, suppresses aldosterone, and preserves GFR without reducing blood pressure in a proof-of-concept study in patients with chronic heart failure

✍ Lisa C Costello-Boerrigter; John A Schirger; Wayne L Miller; Guido Boerrigter; H 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 135 KB

Costello-Boerrigter et al.: Cenderitide (CD-NP), a novel peptide designed to activate both guanylyl cyclase B and A, activates the second messenger cGMP, suppresses aldosterone, and preserves GFR without reducing blood pressure in a proof-of-concept study in patients with chronic heart failure.

Acute and Chronic Toxicity of Veratrum V

Acute and Chronic Toxicity of Veratrum Viride††The Veratrum viride studied was the whole-powdered drug marketed by Irwin, Neisler & Co. under the name, Vertavis. The work reported herein was supported by a grant from this firm. The batch of powder used in these experiments was stated by the manufacturer to have been assayed biologically by the Craw method on Daphnia magna. One Craw unit of the material studied was stated to be 15.6mg. With regard to this assay, Mr. R. O. Craw has been so kind as to allow us to publish a brief explanation: A reference lot of Yerolrum oirid; powder was set-aside as a standard and a 10% w/v aqueous extract was made of this powder. The average median length of life in 50 assays of 1000 daphnia on immersion in the solution was determined to be 2.22 hours. The daphnia were considered dead when the heart was found to be in systolic standstill on microscopic examination. Succeeding lots of powder were assayed and their potency determined by relating the median length of life of daphnia to 2.22 hours, which is one unit. Twenty assays of 10 animals each were used on each lot of powder.‡‡The authors wish to thank Dr. J. F. A.,McManus of the Department of Pathology for a pathologic report on the tissues, and Mr. James Thomas and Mrs. Bobby E. Teague for technical assistance.

✍ Perdue, Adoline S. ;Bell, Frances ;Starnes, W.R. ;Hitchcock, Philip ;Teague, R.S 📂 Article 📅 1950 🏛 Elsevier ⚖ 346 KB 👁 1 views